Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025)
Powered by 
Analysis
Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 32.23% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | 40.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 40.12% |
| Sep 30, 2025 | 20.33% |
| Jun 30, 2025 | 12.61% |
| Mar 31, 2025 | 15.94% |
| Dec 31, 2024 | 16.82% |
| Sep 30, 2024 | -17.82% |
| Jun 30, 2024 | -24.85% |
| Mar 31, 2024 | -32.11% |
| Dec 31, 2023 | -17.51% |
| Sep 30, 2023 | -19.64% |
| Jun 30, 2023 | -5.85% |
| Mar 31, 2023 | -12.29% |
| Dec 31, 2022 | 6.18% |
| Sep 30, 2022 | 19.68% |
| Jun 30, 2022 | 15.35% |
| Mar 31, 2022 | 11.91% |
| Dec 31, 2021 | 33.39% |
| Sep 30, 2021 | 11.50% |
| Jun 30, 2021 | 5.64% |
| Mar 31, 2021 | 7.16% |